MB: FDA recently approved the first absorbable fibrin sealant patch to prevent bleeding from small blood vessels during cardiovascular surgery. It's called TachoSil and it's made by Nycomed. The patch provides an additional tool for surgeons to help control mild and moderate bleeding when standard surgical techniques are ineffective or impractical. It should not be used intravascularly.
AR: The effectiveness of TachoSil was evaluated in a study of 119 cardiovascular surgery patients. Nearly three-quarters of the group who received TachoSil stopped bleeding within three minutes, compared to about one third of the comparator group. Adverse reaction rates were not statistically different between the two groups.

标题
Absorbable Surgical Sealant Patches (FDA)

视频介绍
FDA Patient Safety News - June, 2010 - Show #99
FDA recently approved TachoSil, the first absorbable fibrin sealant patch to prevent bleeding from small blood vessels during cardiovascular surgery.

Speaker #1: Mark Barnett (MB), Assistant Director, Education & Communication, U.S. Food and Drug Administration

Speaker #2: Anita Rayner (AR), Associate Director, Policy & Communications, U.S. Food and Drug Administration